Ukr.Biochem.J. 2025; Volume 97, Issue 2, Mar-Apr, pp. 31-40

doi: https://doi.org/10.15407/ubj97.02.031

Efficacy of human heparin-binding EGF-like growth factor in healing experimental chemical burns

05.05.2025   Uncategorized   No comments

L. M. Dronko1, T. M. Lutsenko1*, O. I. Golembiovska1,
T. Yu. Trokhymchuk2, M. A. Arkhypova2, V. A. Dibrova2, Yu. V. Dibrova2,
S. L. Rybalko2, S. A. Myakushko3, A. A. Siromolot3,4, O. Yu. Galkin1,4

1National Technical University of Ukraine “Igor Sikorsky Kyiv Polytechnic Institute”, Kyiv;
2SІ “L.V. Gromashevskyi Institute of Epidemiology and Infectious Diseases
of the NAMS of Ukraine”, Kyiv, Ukraine;
3ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, Ukraine;
4Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, Kyiv;
*e-mail: lutsenko.tetiana@lll.kpi.ua

Received: 25 December 2024; Revised: 07 February 2025;
Accepted: 25 April 2025; Available on-line: 12 May 2025

According to the WHO, burns are the third most common cause of traumatic skin injuries. Chemical burns are characterized by a complex course and a long healing process. The use of the representatives of the epidermal growth factor family seems to be a promising direction in the treatment of chemical burns. The aim of this study was to evaluate the effectiveness of the recombinant human heparin-binding EGF-like growth factor (rhHB-EGF) in treating burn wounds in mice. The expression of a recombinant human HB-EGF analog was induced in the prokaryotic system E. coli BL21 Star, the protein was isolated, purified and its preparations in PBS or in a form of gel containing sodium hyaluronate and potassium sorbate were obtained. The burn wound was simulated in white non-inbred mice by subcutaneous injection of 10% paraformaldehyde solution, healing was observed for 17 days. The initial wound area was measured on the 7th day after the burn injury when the treatment was started. The mice with burn injury were divided into groups of 3 each – untreated mice (control), treated with different preparations: gel without rhHB-EGF; rhHB-EGF in a gel form; rhHB-EGF in PBS solution. The preparations (100 μl, 1.5 mg of rhHB-EGF) were applied to burn wounds daily for 5 days. Wound area, healing rate and histological patterns of skin samples were estimated. It was shown that groups with burn injury treated with HB-EGF protein (both in solution and gel form) demonstrated an advantage in reducing the wound area and inflammatory cells infiltration, improving healing rate, increasing the proliferative activity of epithelial cells and neovascularization as compared with the untreated group. Thus, the use of rhHB-EGF is a promising direction in the treatment of skin wounds.

Keywords: , , , ,

References:

  1. World Health Organization. Burns [Electronic resource] // World Health Organization, 2023. Available at: https://www.who.int/news-room/fact-sheets/detail/burns (accessed: November 5, 2024).
  2. Papuga AYe, Lukash LL. Different types of biotechnological wound coverages created with the application of alive human cells. Biopolym Cell. 2015;31(2):83-96. CrossRef
  3. Giretzlehner M, Ganitzer I, Haller H. Technical and Medical Aspects of Burn Size Assessment and Documentation. Medicina (Kaunas). 2021;57(3):242. PubMed, PubMedCentral, CrossRef
  4. Makyeyeva L, Frolov O, Aliyeva E. Functional changes in skin mast cells during surgical wound healing in rats after the influence of chronic social stress. Fitoterapia. 2024;(2):36-46. CrossRef
  5. Shin SH, Koh YG, Lee WG, Seok J, Park KY. The use of epidermal growth factor in dermatological practice. Int Wound J. 2023;20(6):2414-2423. PubMed, PubMedCentral, CrossRef
  6. Esquirol Caussa J, Herrero Vila E. Epidermal growth factor, innovation and safety. Med Clin (Barc). 2015;145(7):305-312. PubMed, CrossRef
  7. Değim Z, Çelebi N, Alemdaroğlu C, Deveci M, Öztürk S, Özoğul C. Evaluation of chitosan gel containing liposome-loaded epidermal growth factor on burn wound healing. Int Wound J. 2011;8(4):343-354. PubMed, PubMedCentral, CrossRef
  8. Kao CC, Huang SY, Chiang CH, Lin CH, Chang TC. Corrigendum to “Microencapsulated rhEGF to facilitate epithelial healing and prevent scar formation of cesarean wound: A randomized controlled trial” [Taiwanese Journal of Obstetrics & Gynecology 60 (2021) 468-473]. Taiwan J Obstet Gynecol. 2022;61(1):191. PubMed, CrossRef
  9. Dronko LM, Lutsenko TM, Korotkevych NV, Vovk IO, Zhukova DA, Romaniuk SI, Siromolot AA, Labyntsev AJ, Kolybo DV. Heparin-binding EGF-like growth factor: mechanisms of biological activity and potential therapeutic applications. Ukr Biochem J. 2024;96(5):5-20. CrossRef
  10. Dao DT, Anez-Bustillos L, Adam RM, Puder M, Bielenberg DR. Heparin-Binding Epidermal Growth Factor-Like Growth Factor as a Critical Mediator of Tissue Repair and Regeneration. Am J Pathol. 2018;188(11):2446-2456. PubMed, PubMedCentral, CrossRef
  11. Rodero MP, Khosrotehrani K. Skin wound healing modulation by macrophages. Int J Clin Exp Pathol. 2010;3(7):643-653. PubMed, PubMedCentral
  12. Rocourt DV, Mehta VB, Besner GE. Heparinbinding EGF-like growth factor decreases inflammatory cytokine expression after intestinal ischemia/reperfusion injury. J Surg Res. 2007; 139(2): 269-273.
  13. Ljubimov AV, Saghizadeh M. Progress in corneal wound healing. Prog Retin Eye Res. 2015;49:17-45. PubMed, PubMedCentral, CrossRef
  14. Galkin OYu, Gorshunov YuV, Besarab OB, Ivanova OM. Development and characterization of highly informative ELISA for the detection of IgG and IgA antibodies to Сhlamydia trachomatis. Ukr Biochem J. 2018;90(3):70-83. CrossRef
  15. Galkin OYu, Besarab AB, Lutsenko TN. Characteristics of enzyme-linked immunosorbent assay for detection of IgG antibodies specific to Сhlamydia trachomatis heat shock protein (HSP-60). Ukr Biochem J. 2017;89(1):22-30. CrossRef
  16. Bondarets I, Sidorenko L, Antonenko O, Lebed S, Georgiyants V. An approach to the technological process validation of manufacturing medical devices using the example of injectable implants based on hyaluronic acid. ScienceRise: Pharm Sci. 2024;(6(52)):111–123. CrossRef
  17. Rovee DT, Maibach HI (eds.). The Epidermis in Wound Healing. 1st ed. Boca Raton: CRC Press, 2003. 408 p. CrossRef
  18. Cutting KF, Harding KG. Criteria for identifying wound infection. J Wound Care. 1994;3(4):198-201. PubMed, CrossRef
  19. Rubtsov V, Govbakh I, Ustymenko A, Kyryk V, Tsupykov O. The effects of adipose-derived multipotent mesenchymal stromal cells transplantation on locomotor activity and function of the sciatic nerve in mice with peripheral neuropathy. Cell Organ Transpl. 2020;8(2):159-165. CrossRef
  20. Goltsev A, Bondarovych M, Gaevska Y, Dubrava T, Babenko N, Ostankov M. Modern Methods of Obtaining Immune Dendritic Cells With Anti-Tumor Potential. Innov Biosyst Bioeng. 2024;8(1):56-76. CrossRef
  21. Rozumenko V, Liubich L, Staino L, Egorova D, Dashchakovskyi A, Malysheva T. Cytodestructive Effects of Photodynamic Exposure in Primary Cultures of Malignant Glioma Cells. Innov Biosyst Bioeng. 2024;8(4):48-68. CrossRef
  22. Santoro MM, Gaudino G. Cellular and molecular facets of keratinocyte reepithelization during wound healing. Exp Cell Res. 2005;304(1):274-286. PubMed, CrossRef
  23. Neagu M, Constantin C, Jugulete G, Cauni V, Dubrac S, Szöllősi AG, Zurac S. Langerhans Cells-Revising Their Role in Skin Pathologies. J Pers Med. 2022;12(12):2072. PubMed, PubMedCentral, CrossRef
  24. West HC, Bennett CL. Redefining the Role of Langerhans Cells As Immune Regulators within the Skin. Front Immunol. 2018;8:1941. PubMed, PubMedCentral, CrossRef
  25. Baquerizo Nole KL, Kirsner RS. Hair follicles and their potential in wound healing. Exp Dermatol. 2015;24(2):95-96. PubMed, CrossRef
  26. Nuutila K. Hair Follicle Transplantation for Wound Repair. Adv Wound Care (New Rochelle). 2021;10(3):153-163. PubMed, PubMedCentral, CrossRef
  27. Jimenez F, Poblet E, Izeta A. Reflections on how wound healing-promoting effects of the hair follicle can be translated into clinical practice. Exp Dermatol. 2015;24(2):91-94. PubMed, CrossRef
  28. Rippa AL, Kalabusheva EP, Vorotelyak EA. Regeneration of Dermis: Scarring and Cells Involved. Cells. 2019;8(6):607. PubMed, PubMedCentral, CrossRef
  29. Cribbs RK, Harding PA, Luquette MH, Besner GE. Endogenous production of heparin-binding EGF-like growth factor during murine partial-thickness burn wound healing. J Burn Care Rehabil. 2002;23(2):116-125. PubMed, CrossRef
  30. Ustymenko A, Kyryk V, Tsupykov O, Parkhomenko O. Prospects for cytokinesis-block micronucleus cytome assay in the comprehensive evaluation of cellular senescence markers. Cell Organ Transpl. 2024; 12(2):e2024122172. CrossRef
  31. Stoll SW, Rittié L, Johnson JL, Elder JT. Heparin-binding EGF-like growth factor promotes epithelial-mesenchymal transition in human keratinocytes. J Invest Dermatol. 2012;132(9):2148-2157. PubMed, PubMedCentral, CrossRef
Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.